Research Analysts Set Expectations for CRDL Q1 Earnings
Cardiol Therapeutics Inc. (NASDAQ:CRDL – Free Report) – Stock analysts at Roth Capital lowered their Q1 2025 EPS estimates for shares of Cardiol Therapeutics in a report issued on Wednesday, April 16th. Roth Capital analyst J. Wittes now forecasts that the company will post earnings per share of ($0.13) for the quarter, down from their […]
